Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Verstraete

Showing results (121-130 of 414) with videos related to

Pageof 42
Sort By:
Clinics in Haematology|May 1, 1986
Pharmacology of the interaction between platelets and vessel wallM Verstraete, J Kienast
Bulletin De L'Academie Nationale De Medecine|October 1, 1985
[Tissue plasminogen activator, a new specific thrombolytic of fibrin. Molecular mechanisms and clinical application]M Verstraete, D Collen
Journal Des Maladies Vasculaires|January 1, 1987
[Molecular defects of coagulation factors and of the fibrinolytic system associated with thromboembolism]M Verstraete, J Vermylen
Angiologica|January 1, 1970
Multifocal fibrotic diathesis. An often overlooked cause of venae cavae syndromeM Verstraete, J Vandenbroucke
Angiologica|January 1, 1970
The clinical significance of communication between abdominal splanchnic arteriesM Verstraete, J Vandenbroucke
Acta Chirurgica Belgica|June 1, 1997
Prophylaxis of venous thromboembolism in surgeryR Verhaeghe, M Verstraete
Presse Medicale (Paris, France : 1983)|April 5, 1986
[Intracoronary thrombolysis or brief intravenous infusion of high-dose streptokinase in the treatment of acute myocardial infarction]M Verstraete, H Bounameaux
Journal of Veterinary Dentistry|May 25, 2005
ClarificationFrank J M Verstraete
Thrombosis Research|January 1, 1979
alpha 2-Antiplasmin consumption and fibrinogen breakdown during thrombolytic therapyD Collen, M Verstraete
Acta Clinica Belgica|January 1, 1975
Laboratory and clinical evaluation of concentrates for treatment of haemophiliaM Verstraete, J Vermylen
Pageof 42

Showing results (121-130 of 414) with videos related to

Sort By:
Pageof 42
Clinics in Haematology|May 1, 1986
Pharmacology of the interaction between platelets and vessel wallM Verstraete, J Kienast
Bulletin De L'Academie Nationale De Medecine|October 1, 1985
[Tissue plasminogen activator, a new specific thrombolytic of fibrin. Molecular mechanisms and clinical application]M Verstraete, D Collen
Journal Des Maladies Vasculaires|January 1, 1987
[Molecular defects of coagulation factors and of the fibrinolytic system associated with thromboembolism]M Verstraete, J Vermylen
Angiologica|January 1, 1970
Multifocal fibrotic diathesis. An often overlooked cause of venae cavae syndromeM Verstraete, J Vandenbroucke
Angiologica|January 1, 1970
The clinical significance of communication between abdominal splanchnic arteriesM Verstraete, J Vandenbroucke
Acta Chirurgica Belgica|June 1, 1997
Prophylaxis of venous thromboembolism in surgeryR Verhaeghe, M Verstraete
Presse Medicale (Paris, France : 1983)|April 5, 1986
[Intracoronary thrombolysis or brief intravenous infusion of high-dose streptokinase in the treatment of acute myocardial infarction]M Verstraete, H Bounameaux
Journal of Veterinary Dentistry|May 25, 2005
ClarificationFrank J M Verstraete
Thrombosis Research|January 1, 1979
alpha 2-Antiplasmin consumption and fibrinogen breakdown during thrombolytic therapyD Collen, M Verstraete
Acta Clinica Belgica|January 1, 1975
Laboratory and clinical evaluation of concentrates for treatment of haemophiliaM Verstraete, J Vermylen
Pageof 42